Related Experiment Video

Updated: Sep 4, 2025

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.2K

Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections

E Díaz Santos1, C Mora Jiménez2, L Del Río-Carbajo3

  • 1Medicina Intensiva, Consorci Corporació Sanitaria Parc Taulí, Sabadell, Barcelona, Spain; Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Medicina Intensiva
|July 15, 2022
PubMed

Insights

Pseudomonas aeruginosa frequently causes ICU infections, particularly ventilator-associated pneumonia. New antibiotics offer hope against multi-drug resistant strains, addressing treatment challenges.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Microbiology

Background:

  • Pseudomonas aeruginosa is a leading cause of intensive care unit (ICU)-acquired infections, especially ventilator-associated pneumonia.
  • Infections caused by this pathogen are severe and difficult to treat due to high rates of antibiotic resistance.
  • This poses a significant challenge in managing critically ill patients.

Purpose of the Study:

  • To review the distinct features of Pseudomonas aeruginosa infections.
  • To analyze emerging therapeutic strategies for Pseudomonas aeruginosa, with a focus on multi-drug resistant (MDR) strains.
  • To provide an overview of new antibiotic options against resistant Pseudomonas aeruginosa.

Main Methods:

  • Literature review of studies on Pseudomonas aeruginosa infections.
  • Analysis of antimicrobial resistance patterns.
  • Evaluation of recently developed antibiotics and their efficacy.
  • Focus on clinical characteristics and treatment outcomes.

Main Results:

  • Pseudomonas aeruginosa exhibits significant prevalence in ICU settings.
  • High levels of resistance to first-line antibiotics are documented.
  • New antibiotics demonstrate activity against MDR Pseudomonas aeruginosa strains.
  • These novel agents offer potential for improved treatment outcomes.

Conclusions:

  • Pseudomonas aeruginosa remains a critical pathogen in ICUs.
  • Antimicrobial resistance necessitates the development of new therapeutic agents.
  • Emerging antibiotics show promise in combating MDR Pseudomonas aeruginosa infections.
  • Further research and clinical application of these new options are warranted.
Keywords:
Bacilo gramnegativoBacterias multirresistentesGramnegative bacillusMultidrug-resistant bacteriaNeumonía asociada a la ventilaciónPseudomonas aeruginosaVentilator-associated pneumonia

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.0K
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

1.2K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
437
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
35
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
232
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
530
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
88
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.6K